Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 4Unknown 1Recruiting 1Active not recruiting 1

Sponsor Class

FED 2OTHER 1INDUSTRY 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Lymphoid 4CNS 4Gastrointestinal 3Sarcoma 2Other hematologic neoplasm 2Genitourinary 2Thoracic 1Plasma cell 1Myeloid 1Head & Neck 1Gynecologic 1Dermatologic 1Classical hematology 1Breast 1

Conditions

Brain Neoplasms 1053Glioblastoma 921Glioma 604Central Nervous System Neoplasms 436Astrocytoma 396Gliosarcoma 339Neuroblastoma 325Oligodendroglioma 255Neoplasms 182Medulloblastoma 165Breast Neoplasms 154Sarcoma 114Recurrence 108Ependymoma 105Neoplasm Metastasis 96Meningioma 91Melanoma 88Lymphoma 87Carcinoma, Non-Small-Cell Lung 87Lung Neoplasms 83Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Neurofibromatosis 1 79Wilms Tumor 75Osteosarcoma 69Head and Neck Neoplasms 69Ovarian Neoplasms 68Testicular Neoplasms 67Lymphoma, Non-Hodgkin 67Burkitt Lymphoma 66Familial ependymoma 63

Interventions

Streptozocin 1Mercaptopurine 1Carmustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Rare Diseases × CNS × Clear all
NCT06714370 2026-05-20

REVEAL

Ono Pharmaceutical Co., Ltd.

Completed
24 enrolled
CNSLymphoid

Brain Neoplasms, Lymphoma, Rare Diseases

NCT05245123 2024-06-11

PsyRareCare

Universitätsklinikum Hamburg-Eppendorf

Completed
100 enrolled
CNSGastrointestinalGenitourinary

Wilms Tumor, Neuroblastoma, Hepatoblastoma, Rare Diseases

NCT00004437 2015-03-25

Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2

FDA Office of Orphan Products Development

Phase 2 Completed
CNS

Mental Disorders, Neurologic Manifestations, Neuroma, Acoustic, Neurofibromatosis 2, Neurofibromatoses, Genetic Diseases, Inborn, Hearing Loss, Rare Diseases

NCT00004688 2015-03-25

Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms

FDA Office of Orphan Products Development

Phase 2 Completed
35 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Genetic Diseases, Inborn, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡